Amphastar Pharmaceuticals Statistics
Total Valuation
AMPH has a market cap or net worth of $1.15 billion. The enterprise value is $1.56 billion.
| Market Cap | 1.15B |
| Enterprise Value | 1.56B |
Important Dates
The last earnings date was Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AMPH has 47.14 million shares outstanding. The number of shares has decreased by -3.73% in one year.
| Current Share Class | 47.14M |
| Shares Outstanding | 47.14M |
| Shares Change (YoY) | -3.73% |
| Shares Change (QoQ) | -2.77% |
| Owned by Insiders (%) | 8.71% |
| Owned by Institutions (%) | 72.83% |
| Float | 36.19M |
Valuation Ratios
The trailing PE ratio is 8.80 and the forward PE ratio is 7.68. AMPH's PEG ratio is 5.64.
| PE Ratio | 8.80 |
| Forward PE | 7.68 |
| PS Ratio | 1.61 |
| Forward PS | 1.96 |
| PB Ratio | 1.54 |
| P/TBV Ratio | 6.88 |
| P/FCF Ratio | 7.64 |
| P/OCF Ratio | 5.94 |
| PEG Ratio | 5.64 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.29, with an EV/FCF ratio of 10.40.
| EV / Earnings | 11.04 |
| EV / Sales | 2.14 |
| EV / EBITDA | 6.29 |
| EV / EBIT | 8.03 |
| EV / FCF | 10.40 |
Financial Position
The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.87.
| Current Ratio | 2.95 |
| Quick Ratio | 1.92 |
| Debt / Equity | 0.87 |
| Debt / EBITDA | 2.56 |
| Debt / FCF | 4.34 |
| Interest Coverage | 4.74 |
Financial Efficiency
Return on equity (ROE) is 19.90% and return on invested capital (ROIC) is 9.00%.
| Return on Equity (ROE) | 19.90% |
| Return on Assets (ROA) | 7.60% |
| Return on Invested Capital (ROIC) | 9.00% |
| Return on Capital Employed (ROCE) | 13.64% |
| Revenue Per Employee | $360,286 |
| Profits Per Employee | $69,836 |
| Employee Count | 2,028 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 2.40 |
Taxes
In the past 12 months, AMPH has paid $31.12 million in taxes.
| Income Tax | 31.12M |
| Effective Tax Rate | 18.02% |
Stock Price Statistics
The stock price has decreased by -42.34% in the last 52 weeks. The beta is 0.78, so AMPH's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | -42.34% |
| 50-Day Moving Average | 25.98 |
| 200-Day Moving Average | 38.52 |
| Relative Strength Index (RSI) | 45.70 |
| Average Volume (20 Days) | 580,132 |
Short Selling Information
The latest short interest is 3.21 million, so 6.80% of the outstanding shares have been sold short.
| Short Interest | 3.21M |
| Short Previous Month | 2.97M |
| Short % of Shares Out | 6.80% |
| Short % of Float | 8.86% |
| Short Ratio (days to cover) | 4.24 |
Income Statement
In the last 12 months, AMPH had revenue of $730.66 million and earned $141.63 million in profits. Earnings per share was $2.77.
| Revenue | 730.66M |
| Gross Profit | 369.01M |
| Operating Income | 194.70M |
| Pretax Income | 201.63M |
| Net Income | 141.63M |
| EBITDA | 248.30M |
| EBIT | 194.70M |
| Earnings Per Share (EPS) | $2.77 |
Balance Sheet
The company has $236.88 million in cash and $652.53 million in debt, giving a net cash position of -$415.65 million or -$8.82 per share.
| Cash & Cash Equivalents | 236.88M |
| Total Debt | 652.53M |
| Net Cash | -415.65M |
| Net Cash Per Share | -$8.82 |
| Equity (Book Value) | 751.28M |
| Book Value Per Share | 15.76 |
| Working Capital | 388.91M |
Cash Flow
In the last 12 months, operating cash flow was $193.17 million and capital expenditures -$42.95 million, giving a free cash flow of $150.23 million.
| Operating Cash Flow | 193.17M |
| Capital Expenditures | -42.95M |
| Free Cash Flow | 150.23M |
| FCF Per Share | $3.19 |
Margins
Gross margin is 50.50%, with operating and profit margins of 26.65% and 19.38%.
| Gross Margin | 50.50% |
| Operating Margin | 26.65% |
| Pretax Margin | 23.64% |
| Profit Margin | 19.38% |
| EBITDA Margin | 33.98% |
| EBIT Margin | 26.65% |
| FCF Margin | 20.56% |
Dividends & Yields
AMPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.73% |
| Shareholder Yield | 3.73% |
| Earnings Yield | 12.34% |
| FCF Yield | 13.09% |
Analyst Forecast
The average price target for AMPH is $38.00, which is 56.12% higher than the current price. The consensus rating is "Hold".
| Price Target | $38.00 |
| Price Target Difference | 56.12% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 3.88% |
| EPS Growth Forecast (5Y) | 4.34% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AMPH has an Altman Z-Score of 3 and a Piotroski F-Score of 5.
| Altman Z-Score | 3 |
| Piotroski F-Score | 5 |